» Articles » PMID: 27476041

Prevalence and Characterization of Fibrosis in Surveillance Liver Biopsies of Patients with Fontan Circulation

Overview
Journal Hum Pathol
Specialty Pathology
Date 2016 Aug 1
PMID 27476041
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The Fontan operation is a widely used palliative procedure in patients with single-ventricle anatomy that results in liver injury. As timely identification of liver fibrosis may result in management changes to Fontan patients, the aim of our study was to identify clinically meaningful semi quantitative/quantitative pathologic parameters for biopsy assessment. We performed a retrospective review of 74 liver needle biopsies from Fontan patients. Fibrosis was assessed using quantitative % collagen deposition by Sirius red image analysis, METAVIR, congestive hepatic fibrosis score, sinusoidal fibrosis score, and sinusoidal dilation score. Contemporaneous laboratory, hemodynamic, and ultrasound data were collected. Centrilobular and peri sinusoidal fibrosis was observed in all cases, with 39.2% high grade. Portal fibrosis was observed in 93.2%, with 36.2% high-grade (METAVIR F3-F4). Cirrhosis was observed in 5.4%. % Collagen deposition was increased over control tissue (P < .001) and correlated with time from Fontan (r = 0.3, P = .009) and prothrombin time (r = 0.25, P = .034). Mildly elevated prothrombin time/international normalized ratio was the only measure of liver function consistently associated with multiple high-grade fibrosis scores (METAVIR P = .046, sinusoidal fibrosis P = .018). Abnormal liver echotexture on ultrasound was associated with high-grade congestive hepatic fibrosis score (P = .03). Pathologic gradings and %CD correlated with each other (r = 0.48-0.8, P < .001). Hepatic fibrosis in Fontan patients in our study is universally present, appears to be time dependent, and correlates with few laboratory measurements of liver function. Careful assessment of needle liver biopsies lends a more meaningful measure of liver fibrosis in the Fontan patient than clinical and laboratory data, allowing for appropriate changes to patient management.

Citing Articles

Fontan-associated liver disease: the importance of multidisciplinary teamwork in its management.

Tsuchihashi T, Cho Y, Tokuhara D Front Med (Lausanne). 2024; 11:1354857.

PMID: 39664312 PMC: 11631589. DOI: 10.3389/fmed.2024.1354857.


Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners.

Cieplucha A, Budts W, Gewillig M, Van De Bruaene A US Cardiol. 2024; 16:e25.

PMID: 39600838 PMC: 11588172. DOI: 10.15420/usc.2022.02.


Spleen shear wave elastography measurements do not correlate with histological grading of liver fibrosis in Fontan physiology: a preliminary investigation.

Venkatakrishna S, Ghosh A, Gonzalez I, Wilkins B, Serai S, Rand E Pediatr Radiol. 2024; 54(12):1998-2005.

PMID: 39333365 DOI: 10.1007/s00247-024-06052-x.


Liver Biopsy Leads to Serendipitous Diagnosis of Glycogen Storage Disease Type IX in a Patient With Fontan-Associated Liver Disease.

Hyer E, Alexander C, Rand E, Diamond T JPGN Rep. 2023; 4(4):e377.

PMID: 38034453 PMC: 10684236. DOI: 10.1097/PG9.0000000000000377.


Mitochondrial dysfunction is associated with the severity of liver fibrosis in patients after the Fontan operation.

Sethasathien S, Leemasawat K, Silvilairat S, Sittiwangkul R, Makonkawkeyoon K, Leerapun A J Cell Mol Med. 2023; 28(2):e18035.

PMID: 37966270 PMC: 10826431. DOI: 10.1111/jcmm.18035.